Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$41.99 - $62.38 $37,581 - $55,830
895 Added 59.99%
2,387 $140,000
Q3 2023

Nov 14, 2023

SELL
$27.8 - $45.35 $369,128 - $602,157
-13,278 Reduced 89.9%
1,492 $64,000
Q2 2023

Aug 14, 2023

BUY
$36.13 - $49.49 $389,517 - $533,551
10,781 Added 270.27%
14,770 $533,000
Q1 2023

May 09, 2023

SELL
$36.54 - $54.26 $281,102 - $417,422
-7,693 Reduced 65.85%
3,989 $148,000
Q4 2022

Feb 10, 2023

BUY
$41.27 - $98.62 $231,400 - $552,962
5,607 Added 92.3%
11,682 $529,000
Q3 2022

Nov 10, 2022

SELL
$59.5 - $86.7 $518,899 - $756,110
-8,721 Reduced 58.94%
6,075 $424,000
Q2 2022

Aug 15, 2022

BUY
$39.16 - $88.71 $228,929 - $518,598
5,846 Added 65.32%
14,796 $994,000
Q1 2022

May 12, 2022

BUY
$75.82 - $150.97 $527,252 - $1.05 Million
6,954 Added 348.4%
8,950 $736,000
Q4 2021

Feb 14, 2022

BUY
$132.01 - $190.29 $99,799 - $143,859
756 Added 60.97%
1,996 $293,000
Q3 2021

Nov 15, 2021

SELL
$132.13 - $177.45 $387,801 - $520,815
-2,935 Reduced 70.3%
1,240 $219,000
Q2 2021

Aug 16, 2021

BUY
$144.0 - $179.73 $267,984 - $334,477
1,861 Added 80.42%
4,175 $675,000
Q1 2021

May 17, 2021

SELL
$158.92 - $221.61 $116,965 - $163,104
-736 Reduced 24.13%
2,314 $396,000
Q4 2020

Feb 16, 2021

SELL
$162.05 - $240.27 $46,994 - $69,678
-290 Reduced 8.68%
3,050 $670,000
Q3 2020

Nov 16, 2020

BUY
$113.26 - $167.27 $108,389 - $160,077
957 Added 40.16%
3,340 $554,000
Q2 2020

Aug 13, 2020

BUY
$72.01 - $120.39 $169,799 - $283,879
2,358 Added 9432.0%
2,383 $272,000
Q1 2020

May 15, 2020

SELL
$69.78 - $116.21 $42,914 - $71,469
-615 Reduced 96.09%
25 $2,000
Q4 2019

Feb 07, 2020

SELL
$70.76 - $128.86 $56,466 - $102,830
-798 Reduced 55.49%
640 $82,000
Q3 2019

Nov 05, 2019

BUY
$77.91 - $109.6 $112,034 - $157,604
1,438 New
1,438 $112,000
Q2 2019

Aug 13, 2019

SELL
$59.49 - $104.71 $69,484 - $122,301
-1,168 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$43.65 - $78.95 $50,895 - $92,055
1,166 Added 58300.0%
1,168 $86,000
Q4 2018

Feb 14, 2019

SELL
$32.0 - $47.43 $14,656 - $21,722
-458 Reduced 99.57%
2 $0
Q3 2018

Nov 13, 2018

BUY
$47.1 - $62.7 $21,666 - $28,842
460 New
460 $22,000
Q2 2018

Aug 15, 2018

SELL
$26.05 - $52.4 $59,003 - $118,686
-2,265 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$17.2 - $34.95 $11,919 - $24,220
693 Added 44.08%
2,265 $70,000
Q4 2017

Feb 09, 2018

BUY
$12.65 - $19.0 $19,885 - $29,868
1,572
1,572 $28,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.